Glatiramer Acetate Injection, Solution
Product Images NDC 47335-991

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Glatiramer Acetate (NDC 47335-991). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Glatirtamer Actetate Injection (Glatiramer Acetate 40 mg Per mL 1)

FDA Label Image

Figure G (Glatiramer Acetate 40 mg Per mL 10)

FDA Label Image

Figure H (Glatiramer Acetate 40 mg Per mL 11)

FDA Label Image

Figure I (Glatiramer Acetate 40 mg Per mL 12)

FDA Label Image

Figure J (Glatiramer Acetate 40 mg Per mL 13)

FDA Label Image

Figure K (Glatiramer Acetate 40 mg Per mL 14)

FDA Label Image

Figure L (Glatiramer Acetate 40 mg Per mL 15)

FDA Label Image

Logo Sun Pharma (Glatiramer Acetate 40 mg Per mL 16)

FDA Label Image

Glatiramer Acetate Injection 40 mg/ml (Box)

This is a medication packaging containing 12 single-dose pre-filled syringes of Glatiramer Acetate Injection. Each syringe is 40mg/mL for subcutaneous use only. The dosage is three times a week. It is prescribed for the treatment of certain conditions.*

FDA Label Image

Figure 2 Glatiramer Acetate Injection (Glatiramer Acetate 40 mg Per mL 2)

This is a comparison between Glatiramer acetate injection and Placebo over a period of several months. It appears to be related to a study or clinical trial evaluating the effectiveness of Glatiramer acetate injection compared to a placebo.*

FDA Label Image

Logo Sun Pharma (Glatiramer Acetate 40 mg Per mL 3)

This text appears to be indicating a company name "Sun Pharma". Sun Pharma is an Indian multinational pharmaceutical company that manufactures and sells pharmaceutical ingredients. It is one of the largest pharmaceutical companies in India and operates globally.*

FDA Label Image

Figure A (Glatiramer Acetate 40 mg Per mL 4)

FDA Label Image

Figure B (Glatiramer Acetate 40 mg Per mL 5)

FDA Label Image

Figure C (Glatiramer Acetate 40 mg Per mL 6)

This text provides guidelines for body measurements and specifies the areas to avoid while measuring. It mentions particular areas on the abdomen, back of hips and arms, upper back portion of the arms, thighs, and arms where measurements should be focused. The instructions also include specific distances from certain landmarks to ensure accurate measurements.*

FDA Label Image

Figure D (Glatiramer Acetate 40 mg Per mL 7)

FDA Label Image

Figure E (Glatiramer Acetate 40 mg Per mL 8)

FDA Label Image

Figure F (Glatiramer Acetate 40 mg Per mL 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.